Customize your JAMA Network experience by selecting one or more topics from the list below.
Copyright 2015 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
In the article titled “Intralesional Rituximab in the Treatment of Refractory Oral Pemphigus Vulgaris,” published online December 23, 2014, in JAMA Dermatology (doi:10.1001/jamadermatol.2014.3674), incorrect images appeared in a figure. As a result of human error, Figure 2A was inadvertently published upside down. Both images in Figure 2 are now replaced. In addition, the figure caption should have read as follows: “Clinical photographs of the right buccal mucosa in patient 3 show progress of oral PV with rituximab treatment. A, Pretreatment photograph showing persistent oral erosions. B, Posttreatment photograph at week 16 showing complete healing.” This article was corrected online.
Incorrect Figure. JAMA Dermatol. 2015;151(6):680. doi:10.1001/jamadermatol.2015.1240
Create a personal account or sign in to: